Aluminum Acetate

Summary

Aluminum Acetate (CHEMBL1201015) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 204.11 Da · C6H9AlO6

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201015
Name	Aluminum Acetate
Type	Small molecule
Max phase	4
FDA approved	yes
PubChem CID	8757
Molecular formula	C6H9AlO6
Molecular weight	204.11
InChIKey	WCOATMADISNSBV-UHFFFAOYSA-K

SMILES: CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]

IUPAC name: aluminum triacetate

Also known as: Acetic acid, aluminum salt, Acetic acid, aluminum salt (3:1), Aluminium acetate, Aluminum acetate, Aluminum acetate component of borofair, Buro-sol, Domeboro, ALUMINUM ACETATE

Patent coverage: 7,494 distinct patent families (19,414 SureChEMBL compound mentions), from 3 matched compound structure(s). One matched structure accounts for 19,295 (99%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).